No Data
Roche Holding Non-GAAP EPS of CHF 10.23, Revenue of CHF 29.85B; Raises FY24 Outlook
Everything You Need to Know on Thursday: RBC Restructures, Divides Key Banking Division into Two
TD, Royal Bank of Canada Mute Declines in Barrick, Newmont, Sending TSX Higher
Reported Thursday, Roche's Genentech Halts SKYSCRAPER-06 Trial After Tiragolumab Plus Tecentriq And Chemotherapy Show Reduced Efficacy Compared To Comparator Arm
Roche's Genentech Receives FDA Approval For Vabysmo Prefilled Syringe (PFS) To Treat Three Leading Causes Of Vision Loss
2024 Half-Year Recap | 10 Dividend-Monster Stocks in Canadian Market
102159783 : why schd still drop while another ef up